IRIS
NOBILI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 687
NA - Nord America 484
AS - Asia 101
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 1.280
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 482
IE - Irlanda 323
SE - Svezia 193
IT - Italia 113
SG - Singapore 74
RU - Federazione Russa 22
VN - Vietnam 12
DE - Germania 11
CN - Cina 7
UA - Ucraina 7
GB - Regno Unito 6
BR - Brasile 4
CZ - Repubblica Ceca 4
IN - India 4
PL - Polonia 4
EU - Europa 3
FI - Finlandia 3
CA - Canada 2
ID - Indonesia 2
TH - Thailandia 2
NZ - Nuova Zelanda 1
RO - Romania 1
Totale 1.280
Salva come PNG Salva come JPEG
Città #
Dublin 323
Princeton 172
Altamura 90
Jacksonville 79
Wilmington 56
Singapore 41
Chandler 22
Norwalk 15
Dong Ket 12
Chicago 6
London 6
New York 5
Brno 4
Hangzhou 4
Ashburn 3
Helsinki 3
Nanjing 3
Santa Clara 3
Andover 2
Chieti 2
Fairfield 2
Florence 2
Frankfurt am Main 2
Massarosa 2
Milan 2
Nuremberg 2
Phuket 2
Secaucus 2
Toronto 2
Auckland 1
Boardman 1
Bonn 1
Camerino 1
Council Bluffs 1
Furth im Wald 1
Laurel 1
Mountain View 1
Pune 1
Redmond 1
Redwood City 1
Rome 1
San Mateo 1
Sant'Eusanio del Sangro 1
Washington 1
Woodbridge 1
Totale 885
Salva come PNG Salva come JPEG
Nome #
Specific markers, micro-environmental anomalies and tropism: opportunities for gold nanorods targeting of tumors in laser-induced hyperthermia 37
2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds 32
DPYD gene activity score (GAS) predicts dose-limiting toxicity in fluoropyrimidine-treated colorectal cancer patients 31
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice 29
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 29
Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents 29
Efficacy evaluation of plant products in the treatment of erectile dysfunction related to diabetes 29
Oxaliplatinum and 5-fluorouracil in protracted infusion in the treatment of advanced colorectal cancer 28
Cellular pharmacology of gemcitabine 27
Association of the HLA-G 3′UTR polymorphisms with colorectal cancer in Italy: A first insight 26
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 25
Druggable targets in pancreatic adenocarcinoma 24
The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways 23
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 23
Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment 22
Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(ii) compounds with sulfur and phosphorus donors 22
A potential novel drug combination for adjuvant therapy in lung cancer: reflections on an early phase of clinical development 21
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 21
Immune checkpoint inhibitors in pre-treated gastric cancer patients: Results from a literature-based meta-analysis 21
Clinical outcomes and safety of patients treated with NAb-Paclitaxel plus Gemcitabine in metastatic pancreatic cancer: the NAPA study 20
TRK fusion positive cancers: From first clinical data of a TRK inhibitor to future directions 20
Chronic inflammation in urothelial bladder cancer 20
Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy 20
Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer 20
Establishment and characterization of a new spontaneously immortalized ER -/PR -/HER2 + human breast cancer cell line, DHSF-BR16 20
PNN and KCNQ1OT1 Can Predict the Efficacy of Adjuvant Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer Patients 20
Snail immunohistochemical overexpression correlates to recurrence risk in non-muscle invasive bladder cancer: results from a longitudinal cohort study 19
A clinical-genetic score to identify surgically resected colorectal cancer patients benefiting from an adjuvant fluoropyrimidine-based therapy 19
Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer 19
Does surgical prophylaxis with teicoplanin constitute a therapeutic advance? 19
Editorial: Multidrug resistance in cancer: Pharmacological strategies from basic research to clinical issues 19
Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer 19
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines 19
Identification of pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B-cell lymphoma 18
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression 18
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer 18
HLA-G 3'UTR polymorphisms impact the prognosis of stage II-III CRC patients in fluoropyrimidine-based treatment 18
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer 18
Gold compounds as anticancer agents: Chemistry, cellular pharmacology, and preclinical studies 18
Prognostic factors in primary and iterative surgery of colorectal liver metastases 18
Role of ATP-binding cassette transporters in cancer initiation and progression 17
Vinorelbine in non-small cell lung cancer: Real-world data from a single-institution experience 17
Some suggestions from pk/pd principles to contain resistance in the clinical setting—focus on icu patients and gram-negative strains 17
TAS-102 in gastric cancer: Development and perspectives of a new biochemically modulated fluroropyrimidine drug combination 17
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 17
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 17
Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2′-pyridyl)benzimidazole as ligand: Comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivatives 17
Proteomic analysis of the cytotoxic effects induced by the organogold(iii) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication 17
Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors 17
Emerging drugs in refractory colorectal cancer 17
Proteomic analysis of ovarian cancer cell responses to cytotoxic gold compounds 17
Treatment of locally advanced hepatocellular carcinoma by hepatic intra-artery chemotherapy: A pilot study 17
Oxaliplatin plus Raltitrexed in the treatment of patients with advanced colorectal cancer: A phase II study 17
Focus on biochemical and clinical predictors of response to immune checkpoint inhibitors in metastatic urothelial carcinoma: Where do we stand? 17
Increased Expression of VANGL1 is Predictive of Lymph Node Metastasis in Colorectal Cancer: Results from a 20-Gene Expression Signature 17
Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge 17
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 16
An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC) 16
Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis? 16
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipyc 16
Natural compounds for cancer treatment and prevention 16
Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil 16
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 16
Genomic and genetic alterations infuence the progression of gastric cancer 16
Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, In combination with cisplatin In patients with advanced non-small-cell lung cancer 16
Nanoparticle albumin-bound paclitaxel: a big nano for the treatment of gastric cancer 15
Transcriptional subtyping and CD8 immunohistochemistry identifies patients with stage II and III colorectal cancer with poor prognosis who benefit from adjuvant chemotherapy 15
In vitro study on the safety of near infrared laser therapy in its potential application as postmastectomy lymphedema treatment 15
Exploring the biochemical mechanisms of cytotoxic gold compounds: A proteomic study 15
In vitro assessment of antibody-conjugated gold nanorods for systemic injections 15
Size dependent biological profiles of PEGylated gold nanorods 15
Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand 15
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 14
Role of novel hormonal therapies in the management of non-metastatic castration-resistant prostate cancer: a literature-based meta-analysis of randomized trials 14
The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics 14
High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer 14
Pharmacogenetics: Implementing personalized medicine 14
Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules 14
Insights into the role of matrix metalloproteinases in precancerous conditions and in colorectal cancer 14
Preliminary results of a survey of the use of antimicrobial agents as prophylaxis in orthopedic surgery 13
Genotype-driven phase I study of irinotecan administered in combination with fluorouracil/leucovorin in patients with metastatic colorectal cancer 13
Postoperative chemotherapy in resected gastric cancer: Results of a single center experience 13
Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma 13
Maintenance in gastric cancer: New life for an old issue? 13
Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties 12
Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: Solution behavior, reactions with model proteins, antiproliferative properties 12
Optimizing aspirin dose for colorectal cancer patients through deep phenotyping using novel biomarkers of drug action 11
Pharmacological strategies for overcoming multidrug resistance 11
Totale 1.628
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.304
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021454 0 0 0 0 138 227 13 8 14 13 14 27
2021/2022214 1 4 3 2 4 0 2 21 28 6 50 93
2022/2023568 98 98 79 1 3 147 68 21 44 6 3 0
2023/2024304 12 27 20 18 12 82 98 0 0 5 8 22
2024/202588 88 0 0 0 0 0 0 0 0 0 0 0
Totale 1.628